FundedIQ
Health Care

Chitogel

Chitogel is a postoperative hydrogel nasal dressing that can be applied to sinuses after endoscopic sinus surgery. The hydrogel is made by combining chitosan succinamide, dextran aldehyde, and, a sodium phosphate buffer solution. Many patients with chronic sinusitis whose conditions fail to respond to medical treatment require surgery to return their sinus cavities to normal. Chitogel is designed to improve surgical outcomes in the treatment of sinusitis. Chitogel addresses a number of the traditional sinus surgery shortcomings: • Separate tissue or structures compromised by surgical trauma • Prevent adhesions between mucosal surfaces in the nasal cavity • Minimise ostial stenosis • Control minimal bleeding by tamponade effect, blood absorption, and platelet aggregation • Enhance wound healing and the patient experience

www.chitogel.com Wellington, New Zealand 11-50 employees
Total raised
$6.6M
Rounds
1
Latest
Series Unknown
Oct 2024

Chitogel is a postoperative hydrogel nasal dressing that can be applied to sinuses after endoscopic sinus surgery. The hydrogel is made by combining chitosan succinamide, dextran aldehyde, and, a sodium phosphate buffer solution. Many patients with chronic sinusitis whose conditions fail to respond to medical treatment require surgery to return their sinus cavities to normal. Chitogel is designed to improve surgical outcomes in the treatment of sinusitis. Chitogel addresses a number of the traditional sinus surgery shortcomings: • Separate tissue or structures compromised by surgical trauma • Prevent adhesions between mucosal surfaces in the nasal cavity • Minimise ostial stenosis • Control minimal bleeding by tamponade effect, blood absorption, and platelet aggregation • Enhance wound healing and the patient experience

Chitogel has raised $6.6M across 1 round. Its most recent round was a Series Unknown of $6.6M in Oct 2024. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Oct 7, 2024
Series Unknown
$6.6M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Chitogel is featured in

Similar companies

Wellumio

Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.

Seed $4.4M
Kitea Health

Assume you have a persistent illness that will require frequent hospitalisation. Assume too that the only sign of this occurrence was a worsening of symptoms. Reactive management of a number of chronic illnesses is used globally; patients are advised to wait until their symptoms alter before taking any action. At Kitea Health, we aspire to switch from reactive to proactive patient treatment. With tiny implantable devices, we precisely monitor the body's internal pressure. We think that the next generation of implantable technologies—micro-implants—will let people manage their health requirements more effectively and affordably while staying at home and away from hospitals.

Series Unknown $13.0M
Avasa

Avasa is a company in the medical device industry that focuses on enhancing surgical procedures through the creation of innovative implantable devices.

Seed $2.8M
Tend Health Ltd

Tend Health provides various types of Health Care services by providing an easy to use application.

Series Unknown $1.2M
Holobiome

Holobiome is a company that specializes in developing therapies for diseases affecting the enteric and central nervous systems. Using microbiome-based treatments, the company aims to address a range of mental health issues, as well as metabolism and immune responses. Founded in 2015, Holobiome is located in Cambridge, Massachusetts.

Seed $10.0M
Firsthand

Firsthand knowledge of severe mental illness, in our opinion, ought to be valued more. Our founding group of healthcare experts and serial entrepreneurs have purposefully devoted their professional lives to assisting marginalised individuals with serious mental illnesses in collaboration with local nonprofits. We are actively expanding our team with like-minded business creators.

Series Unknown $10.0M
CurieDx

CurieDx is the image-based diagnostics using a smartphone photograph, they assist patients in recovering more quickly.

Seed $200k
Estrigenix Therapeutics

Estrigenix Therapeutics, Inc. is a non-public pharmaceutical company with a goal of creating ground-breaking medications to enhance the mental well-being of women experiencing menopause. Inaugurated in 2018, Estrigenix Therapeutics aims to enhance women's health, starting with addressing the physical and psychological impacts of menopause.

Seed $2.0M
Karoo Health

Karoo Health is a leader in tech-enabled value-based cardiovascular care solutions and aims to bring innovative, end-to-end, cardiovascular solutions to patients via partnerships with health plans and self-insured employers. As a patient-first organization, Karoo Health’s mission is to help patients lead their best lives by providing a new paradigm of better cardiology care, at lower cost, than the current system and preventing the progression of cardiovascular disease.

Series A $16.2M
Neko Health

Neko Health, a health-tech company from Sweden, aims to develop a healthcare system that promotes the maintenance of good health through preventive measures and early detection. Their innovative medical scanning technology concept enables the convenient and cost-effective collection of comprehensive health data, without the need for invasive procedures, making it accessible to the general public.

Series C $700M
410 Medical

A medical device firm called 410 Medical is committed to creating cutting-edge technologies that help doctors provide better treatment for seriously ill patients. The recently approved LifeFlow® PLUS device from 410 is intended to increase the speed and effectiveness of volume resuscitation, enhancing the treatment of patients with life-threatening illnesses such sepsis, bleeding, and cardiac arrest.

Series Unknown $12.0M
Fibroheal

Fibroheal Woundcare Pvt Ltd focuses on leveraging silk proteins to create biomedical applications for effective wound care. The company develops advanced medical devices aimed at addressing various types of wounds, including acute and chronic cases.

Seed $1.5M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.